MORGUARD NORTH AMERICAN (MRG-DB-B.CA) Fundamental Analysis & Valuation

TSX:MRG-DB-B • CA61761EAC45

Current stock price

102.44 CAD
+0.44 (+0.43%)
Last:

This MRG-DB-B.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MRG-DB-B.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MRG-DB-B was profitable.
  • In the past year MRG-DB-B had a positive cash flow from operations.
  • Each year in the past 5 years MRG-DB-B has been profitable.
  • Each year in the past 5 years MRG-DB-B had a positive operating cash flow.
MRG-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFMRG-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

1.2 Ratios

  • MRG-DB-B's Return On Assets of 2.27% is fine compared to the rest of the industry. MRG-DB-B outperforms 73.33% of its industry peers.
  • The Return On Equity of MRG-DB-B (5.16%) is better than 66.67% of its industry peers.
  • MRG-DB-B has a better Return On Invested Capital (3.19%) than 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MRG-DB-B is in line with the industry average of 2.97%.
Industry RankSector Rank
ROA 2.27%
ROE 5.16%
ROIC 3.19%
ROA(3y)2.93%
ROA(5y)4.27%
ROE(3y)6.59%
ROE(5y)9.72%
ROIC(3y)3.2%
ROIC(5y)3.07%
MRG-DB-B.CA Yearly ROA, ROE, ROICMRG-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 29.03%, MRG-DB-B is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • MRG-DB-B's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 53.50%, MRG-DB-B is in line with its industry, outperforming 53.33% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MRG-DB-B has remained more or less at the same level.
  • MRG-DB-B's Gross Margin of 59.85% is on the low side compared to the rest of the industry. MRG-DB-B is outperformed by 80.00% of its industry peers.
  • In the last couple of years the Gross Margin of MRG-DB-B has remained more or less at the same level.
Industry RankSector Rank
OM 53.5%
PM (TTM) 29.03%
GM 59.85%
OM growth 3Y-0.49%
OM growth 5Y-0.36%
PM growth 3Y-28.29%
PM growth 5Y-16.25%
GM growth 3Y-0.88%
GM growth 5Y-0.57%
MRG-DB-B.CA Yearly Profit, Operating, Gross MarginsMRG-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

4

2. MRG-DB-B.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for MRG-DB-B has been reduced compared to 1 year ago.
  • MRG-DB-B has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MRG-DB-B has an improved debt to assets ratio.
MRG-DB-B.CA Yearly Shares OutstandingMRG-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MRG-DB-B.CA Yearly Total Debt VS Total AssetsMRG-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • MRG-DB-B has an Altman-Z score of 1.46. This is a bad value and indicates that MRG-DB-B is not financially healthy and even has some risk of bankruptcy.
  • MRG-DB-B's Altman-Z score of 1.46 is amongst the best of the industry. MRG-DB-B outperforms 100.00% of its industry peers.
  • MRG-DB-B has a debt to FCF ratio of 20.18. This is a negative value and a sign of low solvency as MRG-DB-B would need 20.18 years to pay back of all of its debts.
  • MRG-DB-B has a worse Debt to FCF ratio (20.18) than 73.33% of its industry peers.
  • MRG-DB-B has a Debt/Equity ratio of 0.79. This is a neutral value indicating MRG-DB-B is somewhat dependend on debt financing.
  • MRG-DB-B has a worse Debt to Equity ratio (0.79) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 20.18
Altman-Z 1.46
ROIC/WACCN/A
WACCN/A
MRG-DB-B.CA Yearly LT Debt VS Equity VS FCFMRG-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 0.59 indicates that MRG-DB-B may have some problems paying its short term obligations.
  • MRG-DB-B's Current ratio of 0.59 is amongst the best of the industry. MRG-DB-B outperforms 86.67% of its industry peers.
  • MRG-DB-B has a Quick Ratio of 0.59. This is a bad value and indicates that MRG-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MRG-DB-B's Quick ratio of 0.59 is amongst the best of the industry. MRG-DB-B outperforms 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
MRG-DB-B.CA Yearly Current Assets VS Current LiabilitesMRG-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2

3. MRG-DB-B.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.09% over the past year.
  • MRG-DB-B shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.34% yearly.
  • MRG-DB-B shows a small growth in Revenue. In the last year, the Revenue has grown by 3.04%.
  • The Revenue has been growing slightly by 7.36% on average over the past years.
EPS 1Y (TTM)5.09%
EPS 3Y-19.69%
EPS 5Y-8.34%
EPS Q2Q%-41.12%
Revenue 1Y (TTM)3.04%
Revenue growth 3Y8.39%
Revenue growth 5Y7.36%
Sales Q2Q%0.32%

3.2 Future

  • The Earnings Per Share is expected to decrease by -11.92% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 2.03% on average over the next years.
EPS Next Y-25.86%
EPS Next 2Y-11.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.89%
Revenue Next 2Y2.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MRG-DB-B.CA Yearly Revenue VS EstimatesMRG-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
MRG-DB-B.CA Yearly EPS VS EstimatesMRG-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

0

4. MRG-DB-B.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 54.78, the valuation of MRG-DB-B can be described as expensive.
  • MRG-DB-B's Price/Earnings is on the same level as the industry average.
  • MRG-DB-B is valuated expensively when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 58.97, which means the current valuation is very expensive for MRG-DB-B.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MRG-DB-B indicates a rather expensive valuation: MRG-DB-B more expensive than 80.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of MRG-DB-B to the average of the S&P500 Index (23.84), we can say MRG-DB-B is valued expensively.
Industry RankSector Rank
PE 54.78
Fwd PE 58.97
MRG-DB-B.CA Price Earnings VS Forward Price EarningsMRG-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 93.33% of the companies in the same industry are cheaper than MRG-DB-B, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 40.77
EV/EBITDA N/A
MRG-DB-B.CA Per share dataMRG-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • MRG-DB-B's earnings are expected to decrease with -11.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.92%
EPS Next 3YN/A

5

5. MRG-DB-B.CA Dividend Analysis

5.1 Amount

  • MRG-DB-B has a Yearly Dividend Yield of 4.17%, which is a nice return.
  • Compared to an average industry Dividend Yield of 4.89, MRG-DB-B has a dividend in line with its industry peers.
  • MRG-DB-B's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 4.17%

5.2 History

  • The dividend of MRG-DB-B has a limited annual growth rate of 0.98%.
  • MRG-DB-B is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)0.98%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 25.56% of the earnings are spent on dividend by MRG-DB-B. This is a low number and sustainable payout ratio.
DP25.56%
EPS Next 2Y-11.92%
EPS Next 3YN/A
MRG-DB-B.CA Yearly Income VS Free CF VS DividendMRG-DB-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
MRG-DB-B.CA Dividend Payout.MRG-DB-B.CA Dividend Payout, showing the Payout Ratio.MRG-DB-B.CA Dividend Payout.PayoutRetained Earnings

MRG-DB-B.CA Fundamentals: All Metrics, Ratios and Statistics

MORGUARD NORTH AMERICAN

TSX:MRG-DB-B (3/10/2026, 7:00:00 PM)

102.44

+0.44 (+0.43%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)02-10
Earnings (Next)04-27
Inst Owners3.94%
Inst Owner ChangeN/A
Ins Owners4.54%
Ins Owner ChangeN/A
Market Cap3.58B
Revenue(TTM)354.65M
Net Income(TTM)102.97M
Analysts77.5
Price Target122.53 (19.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.17%
Yearly Dividend0.5
Dividend Growth(5Y)0.98%
DP25.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.54%
PT rev (3m)-12.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.62%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE 54.78
Fwd PE 58.97
P/S 10.09
P/FCF 40.77
P/OCF 40.77
P/B 1.79
P/tB 1.79
EV/EBITDA N/A
EPS(TTM)1.87
EY1.83%
EPS(NY)1.74
Fwd EY1.7%
FCF(TTM)2.51
FCFY2.45%
OCF(TTM)2.51
OCFY2.45%
SpS10.15
BVpS57.1
TBVpS57.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number49.02
Profitability
Industry RankSector Rank
ROA 2.27%
ROE 5.16%
ROCE 4.43%
ROIC 3.19%
ROICexc 3.28%
ROICexgc 3.28%
OM 53.5%
PM (TTM) 29.03%
GM 59.85%
FCFM 24.75%
ROA(3y)2.93%
ROA(5y)4.27%
ROE(3y)6.59%
ROE(5y)9.72%
ROIC(3y)3.2%
ROIC(5y)3.07%
ROICexc(3y)3.24%
ROICexc(5y)3.11%
ROICexgc(3y)3.24%
ROICexgc(5y)3.11%
ROCE(3y)4.44%
ROCE(5y)4.27%
ROICexgc growth 3Y3.17%
ROICexgc growth 5Y-0.46%
ROICexc growth 3Y3.17%
ROICexc growth 5Y-0.46%
OM growth 3Y-0.49%
OM growth 5Y-0.36%
PM growth 3Y-28.29%
PM growth 5Y-16.25%
GM growth 3Y-0.88%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 20.18
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.62
Cash Conversion N/A
Profit Quality 85.23%
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 1.46
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)73.42%
Profit Quality(5y)56.17%
High Growth Momentum
Growth
EPS 1Y (TTM)5.09%
EPS 3Y-19.69%
EPS 5Y-8.34%
EPS Q2Q%-41.12%
EPS Next Y-25.86%
EPS Next 2Y-11.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.04%
Revenue growth 3Y8.39%
Revenue growth 5Y7.36%
Sales Q2Q%0.32%
Revenue Next Year0.89%
Revenue Next 2Y2.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.58%
EBIT growth 3Y7.86%
EBIT growth 5Y6.96%
EBIT Next Year-11.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.88%
FCF growth 3Y5.3%
FCF growth 5Y14.71%
OCF growth 1Y1.88%
OCF growth 3Y5.3%
OCF growth 5Y11.85%

MORGUARD NORTH AMERICAN / MRG-DB-B.CA Fundamental Analysis FAQ

What is the fundamental rating for MRG-DB-B stock?

ChartMill assigns a fundamental rating of 3 / 10 to MRG-DB-B.CA.


What is the valuation status for MRG-DB-B stock?

ChartMill assigns a valuation rating of 0 / 10 to MORGUARD NORTH AMERICAN (MRG-DB-B.CA). This can be considered as Overvalued.


What is the profitability of MRG-DB-B stock?

MORGUARD NORTH AMERICAN (MRG-DB-B.CA) has a profitability rating of 5 / 10.


Can you provide the financial health for MRG-DB-B stock?

The financial health rating of MORGUARD NORTH AMERICAN (MRG-DB-B.CA) is 4 / 10.


What is the expected EPS growth for MORGUARD NORTH AMERICAN (MRG-DB-B.CA) stock?

The Earnings per Share (EPS) of MORGUARD NORTH AMERICAN (MRG-DB-B.CA) is expected to decline by -25.86% in the next year.